October 9, 2014
Our First Dive Into the New Open Payments System
But the issues affected a larger proportion of records than that. Forty percent of payments (more than 1.7 million records) did not include the names of the doctors or hospitals that received the payments; the rest did.
ProPublica has been tracking pharmaceutical company payments to doctors since 2010. This week, we updated our Dollars for Docs tool to include payments from 17 drug companies for the 2013 calendar year. You can search for your doctor by name.Ryann Grochowski Jones and Mike Tigas contributed to this report.
Like this story? Sign up for our daily newsletter to get more of our best work.
There has been an ongoing debate about the effectiveness of chemotherapy drugs for cancer patients as well as their effect on cancer survival rates.
However, American and Australian studies have shown that cancer survival rates after receiving chemotherapy can be as startlingly low as 2.1%.
These studies took a 5-year look at cancer survival rates in cancer patients who received chemotherapy.
The overall contribution of chemotherapy to 5-year survival was found to be just 2.1% for cancer patients in the U.S. and 2.3% for patients in Australia.
While the 5-year cancer survival rate for Australian cancer patients is at this time more than 60%, these studies have shown that the use of chemotherapy makes a negligible contribution.